TOX and invasive breast carcinoma: Given the current limitation of lacking a definitive gene signature to distinguish pre-exhausted CD8+ T cells, we sought to investigate the potential impact of exhaustion-associated factors including the gene expression of TOX, PD-1, and cytotoxic molecules (Perforin and GrzB) on the clinical prognosis of patients with invasive breast carcinoma.